Additional use of a phosphodiesterase 5 inhibitor in patients with pulmonary hypertension secondary to chronic systolic heart failure: a meta-analysis

Treatment of Pulmonary Hypertension Caused by Left Heart Failure With Pulmonary Arterial Hypertension–Specific Therapies

(2013) Lewis J. Rubin   CIRCULATION

Effectiveness and Safety of Phosphodiesterase 5 Inhibitors in Patients with Cardiovascular Disease and Hypertension

(2013) Steven G. Chrysant   CURRENT HYPERTENSION REPORTS

Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND

(2013) F. P. Brouwers et al.   EUROPEAN HEART JOURNAL

PDE5 inhibitors: considerations for preference and long-term adherence

(2013) W. B. Smith et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Effect of Phosphodiesterase-5 Inhibition on Exercise Capacity and Clinical Status in Heart Failure With Preserved Ejection Fraction

(2013) Margaret M. Redfield et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Differences in Hemodynamic Parameters and Exercise Capacity Between Patients With Pulmonary Arterial Hypertension and Chronic Heart Failure

(2013) Ryo Nishio et al.   Journal of Cardiopulmonary Rehabilitation and Prevention

Effects of Phosphodiesterase Type 5 Inhibition on Systemic and Pulmonary Hemodynamics and Ventricular Function in Patients With Severe Symptomatic Aortic Stenosis

(2012) Brian R. Lindman et al.   CIRCULATION

Sildenafil enhances systolic adaptation, but does not prevent diastolic dysfunction, in the pressure-loaded right ventricle

(2012) Marinus A.J. Borgdorff et al.   EUROPEAN JOURNAL OF HEART FAILURE

Sildenafil in Heart Failure (SilHF). An investigator-initiated multinational randomized controlled clinical trial: rationale and design

(2012) Trond J. Cooper et al.   EUROPEAN JOURNAL OF HEART FAILURE

Pulmonary hypertension due to left heart disease: Updated Recommendations of the Cologne Consensus Conference 2011

(2012) Stephan Rosenkranz et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

The effects of phosphodiesterase 5 inhibition on hemodynamics, functional status and survival in advanced heart failure and pulmonary hypertension: A case–control study

(2012) Adrian Reichenbach et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Cyclic Guanosine Monophosphate Signaling and Phosphodiesterase-5 Inhibitors in Cardioprotection

(2012) Rakesh C. Kukreja et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction

(2011) Marco Guazzi et al.   CIRCULATION

Phosphodiesterase 5 inhibition with sildenafil reverses exercise oscillatory breathing in chronic heart failure: a long-term cardiopulmonary exercise testing placebo-controlled study

(2011) Marco Guazzi et al.   EUROPEAN JOURNAL OF HEART FAILURE

Therapeutic potential of sildenafil in patients with heart failure and reactive pulmonary hypertension

(2011) Daniel Dumitrescu et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Oxidative Stress Regulates Left Ventricular PDE5 Expression in the Failing Heart

(2010) Zhongbing Lu et al.   CIRCULATION

PDE5 Inhibition With Sildenafil Improves Left Ventricular Diastolic Function, Cardiac Geometry, and Clinical Status in Patients With Stable Systolic Heart Failure

(2010) Marco Guazzi et al.   Circulation-Heart Failure

Guidelines for the Echocardiographic Assessment of the Right Heart in Adults: A Report from the American Society of Echocardiography

(2010) Lawrence G. Rudski et al.   JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY

Chronic inhibition of phosphodiesterase 5 does not prevent pressure-overload-induced right-ventricular remodelling

(2009) S. Schafer et al.   CARDIOVASCULAR RESEARCH

Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)

(2009) et al.   EUROPEAN HEART JOURNAL

Acute Hemodynamic Effects of Intravenous Sildenafil Citrate in Congestive Heart Failure: Comparison of Phosphodiesterase Type-3 and -5 Inhibition

(2009) Phil Botha et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction

(2009) Carolyn S.P. Lam et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Determinants of Ventilatory Efficiency in Heart Failure

(2008) Gregory D. Lewis et al.   Circulation-Heart Failure

Effects of 5′-Phosphodiesterase Four-Week Long Inhibition With Sildenafil in Patients With Chronic Heart Failure: A Double-Blind, Placebo-Controlled Clinical Trial

(2008) Alice Behling et al.   JOURNAL OF CARDIAC FAILURE